Q32 Bio Inc.
USD15.41
+0.37 (+2.46%)
CEO
Jodie Pope Morrison
IPO Date
2018-03-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$14.91
Prev. Close
$15.04
Day Low
$14.13
Day High
$15.41
52W Low
$1.57
52W High
$23.57
Market Cap
$0.20B
Volume
0.85M
| $2.80 |
| 16 Jun 2026 | LAPORTE KATHLEEN | director | A-Award | Acquired | 9,810 | $12.64 |
| 16 Jun 2026 | Iwicki Mark T | director | A-Award | Acquired | 9,810 | $12.64 |
| 16 Jun 2026 | Manke Isaac | director | A-Award | Acquired | 9,810 | $12.64 |
| 16 Jun 2026 | TZIANABOS ARTHUR | director | A-Award | Acquired | 9,810 | $12.64 |
| 16 Jun 2026 | GRAYZEL DAVID S. | director | A-Award | Acquired | 9,810 | $12.64 |
| 16 Jun 2026 | Thistle Mary | director | A-Award | Acquired | 9,810 | $12.64 |
| 16 Jun 2026 | Xu Diyong | director, 10 percent owner: | A-Award | Acquired | 9,810 | $12.64 |
| 16 Jun 2026 | Lundberg Sven Ante | director | A-Award | Acquired | 9,810 | $12.64 |